Log In
BCIQ
Print this Print this
 

ASP7035

  Manage Alerts
Collapse Summary General Information
Company Tacurion Pharma Inc.
DescriptionVasopressin 2 (V2) receptor agonist
Molecular Target Vasopressin 2 (V2) receptor
Mechanism of ActionVasopressin 2 (V2) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Genitourinary (unspecified)
Indication DetailsTreat nocturia
Regulatory Designation
PartnerDrais Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/13/2013

Undisclosed

0

Undisclosed

Get a free BioCentury trial today